Comparative analysis of the imported segment of the chemical–pharmaceutical veterinary medicinal products market in Ukraine and Poland: market structure, international manufacturers and product portfolios
DOI:
https://doi.org/10.31073/onehealthjournal2026-IV-05Keywords:
veterinary medicinal products, chemical–pharmaceutical veterinary medicinal products, veterinary pharmaceutical market, imported products, international manufacturers, product portfolio, market structure, State Register, Ukraine, PolandAbstract
Ukraine's progress towards European Union integration has created a need for a comprehensive evaluation of the national veterinary medicinal products (VMPs) market and its comparison with those of EU Member States. This study aimed to compare the imported segment of the chemical–pharmaceutical veterinary medicinal products market in Ukraine and the Republic of Poland by analysing its geographical structure, the composition of international manufacturers, and the breadth of their product portfolios. The study was based on the official State Registers of VMPs in Ukraine and the Republic of Poland (March, 2026). Only imported chemical–pharmaceutical veterinary medicinal products (CP-VMPs) were included in the analysis. Bibliographic and content analysis, together with classification, systematisation, structural and comparative analyses, descriptive statistics, and graphical methods, were applied. In addition, a set of structural indicators was developed to evaluate geographical diversification, manufacturer density, and portfolio depth within the imported market segment. Imported CP-VMPs accounted for 487 of 1,186 registered products (41.1 %) in Ukraine and 1,587 of 1,795 (88.4 %) in Poland. The Ukrainian imported segment comprised products from 122 manufacturers representing 39 exporting countries, whereas the Polish market included products from 180 manufacturers representing 22 countries. The average number of manufacturers per exporting country was 3.13 in Ukraine and 8.18 in Poland, while the average number of products per manufacturer reached 4.0 and 8.82, respectively. The corresponding average numbers of products per exporting country were 12.49 and 72.14. These findings demonstrate two distinct models of market organisation. Ukraine is characterised by broad geographical diversification combined with relatively shallow manufacturer portfolios, whereas the Polish market demonstrates a substantially higher concentration of international manufacturers and considerably deeper product portfolios despite a smaller number of exporting countries. Although both markets share a largely common group of leading international manufacturers, the ten largest companies market considerably broader product portfolios in Poland (49 – 138 registered products) than in Ukraine (15–46 registered products). The study proposes a novel set of structural indicators for evaluating imported veterinary pharmaceutical markets by distinguishing geographical diversification, portfolio saturation, and manufacturer presence. The findings indicate that the principal difference between the Ukrainian and Polish markets lies not in the composition of international manufacturers but in the depth and completeness of their product portfolios.
References
Abbood, M. K., Khalaf, H. A. A., Abudlqader, E. H., Taghi, H. S., & Al-Temimi, A. A. (2022). Scope of pharmacovigilance: Comprehensive review. Chemical Science International Journal; 31(5):29–39. doi.:10.9734/CSJI/2022/v31i5822
Abed I., Reilly J., Haughey S., Fleming, G. (2024). Public information on medicine shortages in the European Union and European Economic Area: A review of national reporting systems. European Journal of Hospital Pharmacy; 31(2):92–98. doi.:10.1136/ejhpharm-2022-003554.
Ahmed I., Kasraian K. (2002). Pharmaceutical challenges in veterinary product development. Advanced Drug Delivery Reviews; 54(6):871–882. doi.:10.1016/S0169-409X(02)00074-1.
Bushuieva I. V., Ohloblina M. V. (2023). The current state and prospects for the development of the Ukrainian market of veterinary drugs for the treatment of skin diseases. Current Issues in Pharmacy and Medical Sciences Practice; 16(1):83–89. doi.:10.14739/2409-2932.2023.1.273661.
Čudina N., Zrinsky M., Galić A., et al. (2026). Development of the European veterinary medicines gaps and needs compass for sheep and goats. Veterinary Sciences; 13(3):297. doi.:10.3390/vetsci13030297.
De Briyne N., Gopal R., Diesel G., Iatridou D., O'Rourke D. (2017). Veterinary pharmacovigilance in Europe: A survey of veterinary practitioners. Veterinary Record Open; 4(1):e000224. doi.:10.1136/vetreco-2017-000224.
Dione M. M., Amia W. C., Ejobi F., Ouma E. A., Wieland B. (2021). Supply chain and delivery of antimicrobial drugs in smallholder livestock production systems in Uganda. Frontiers in Veterinary Science; 8:611076. doi.:10.3389/fvets.2021.611076.
European Medicines Agency. (2025). European sales and use of antimicrobials for veterinary medicine: Annual surveillance report for 2023. Publications Office of the European Union. doi.:10.2809/4487470.
European Medicines Agency. (2025). European sales and use of antimicrobials for veterinary medicine: Annual surveillance report for 2024. Publications Office of the European Union. doi.:10.2809/4095842.
European Medicines Agency. (2026). Union Product Database. https://medicines.health.europa.eu/veterinary.
European Parliament, Council of the European Union. (2019). Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC. Official Journal of the European Union; L4:43–167.
Fimbo A. M., Nkansah-Gyekye Y., Mmbando G. S., et al. (2022). Post-marketing surveillance of selected veterinary medicines in Tanzania mainland. BMC Veterinary Research; 18:67. doi.:10.1186/s12917-022-03329-x
Glavind A. S., Kruse A. B., Nielsen L. R., et al. (2022). Monitoring antimicrobial usage in companion animals: Exploring the use of the Danish VetStat database. Acta Veterinaria Scandinavica; 64:27. doi.:10.1186/s13028-022-00647-w.
Grymak A. V. (2022). The potential of the veterinary medicine enterprise: The effectiveness of marketing research in its forming. Scientific and Technical Bulletin of the State Scientific Research Control Institute of Veterinary Medicinal Products and Feed Additives and Institute of Animal Biology; 23(1):53–56. doi.:10.36359/scivp.2022-23-1.07.
Holmes M., Hill R. E. (2007). International harmonisation of regulatory requirements. Revue Scientifique et Technique; 26(2):415–420. doi.:10.20506/rst.26.2.1751.
Jaime G., Hobeika A., Figuié M. (2022). Access to veterinary drugs in Sub-Saharan Africa: Roadblocks and current solutions. Frontiers in Veterinary Science; 8:558973. doi.:10.3389/fvets.2021.558973.
Kang J. W., Park H. C., Jang Y. H., Hossain M. A., Jeong K., Jeong M. Y., Kim Y. J., Lee K. J. (2017). National post-market surveillance assessment of veterinary medicines in Korea during the past decade. BMC Veterinary Research; 13:136. doi.:10.1186/s12917-017-1054-z.
Mekasha Y. T., Nigussie S., Mekonen A. W., Berrie K., Mulaw A., Feleke M. G. (2024). A narrative review of veterinary pharmacovigilance situations and prospects in East African countries. Frontiers in Veterinary Science; 11:1430587. doi.:10.3389/fvets.2024.1430587.
Murungi M., Akol A. M., Kunga J., et al. (2025). National-level consumption of antimicrobials in the veterinary sector in Uganda: Analysis of import data for 2021. Antibiotics; 14(2):150. doi.:10.3390/antibiotics14020150.
Palamar A. O., Kliuiko A. A., Palibroda N. M., Bogdan N. S., Tkachuk O. Y., Shpychak O. S. (2020). Review of the pharmaceutical market of antianemic drugs in Ukraine. Farmatsevtychnyi Chasopys; 4:47–53. doi.:10.11603/2312-0967.2020.4.11646.
Pons-Hernandez M., Wyatt T., Hall A. (2023). Investigating the illicit market in veterinary medicines: An exploratory online study with pet owners in the United Kingdom. Trends in Organized Crime; 26(3):308–328. doi.:10.1007/s12117-022-09463-0.
Ravela R., Airaksinen M., Lyles A. (2023). State of the European Union’s early notification obligation for drug shortages: Enforcement and compliance in eight European countries (2020–2022). Journal of Pharmaceutical Policy and Practice; 16:135. doi.:10.1186/s40545-023-00646-w.
Saliy O. O., Popova M. E., Palchevska T. A., Tarasenko H. V. (2020). Analysis of the assortment of plasma-derived products on the Ukrainian pharmaceutical market. Farmatsevtychnyi Zhurnal; 4:18–29. doi.:10.32352/0367-3057.4.20.02.
Saliy O. O., Popova M. E., Tarasenko H. V., Yarovenko V. S. (2022). The analysis of the main trends in the development of the market of pressurized drugs in pharmaceutical and veterinary practice. Social Pharmacy in Health Care; 8(3):60–70. doi.:10.24959/sphhcj.22.263.
Sander S. E., Bolda S., Heberer T. (2026). National monitoring of veterinary antibiotic sales in Germany from 2011 to 2024. Journal of Consumer Protection and Food Safety; 21:219–224. doi.:10.1007/s00003-026-01609-4.
Semenchuk Y. M., Parashchyn Z. D., Lobur I. P., Stadnytska, N. Y. (2024). Comparative analysis of the Ukrainian and Polish pharmaceutical markets of antifungal drugs for systemic application. Pharmaceutical Review; 2:34–42. doi.:10.11603/2312-0967.2024.2.14745.
Semenchuk Y. T., Stadnytska N. Y. (2024). Antibacterial drugs: Comparative analysis of the Ukrainian and Polish pharmaceutical markets. Health & Education; 4:74–79. doi.:10.32782/health-2024.4.9.
Stasi A. (2025). Why veterinary medicinal products for dogs and cats in the EU cost more than their human equivalents. Research in Veterinary Science; 162:105977. doi.:10.1016/j.rvsc.2025.105977.
Suryawanshi S. J., Jain S., Sharma R. K., Chawla R., Arora S., Shukla V. K., Sharma N. (2024). Current veterinary regulations and way ahead. Research in Veterinary Science; 166:105101. doi.:10.1016/j.rvsc.2023.105101.
Sztabińska-Koncka H., Lewicki J. (1997). Marketing authorization of veterinary medicinal products in Poland. Regulatory Toxicology and Pharmacology; 26(1):129–133. doi.:10.1006/rtph.1997.1103.
Tomas A., Pavlović N., Vukmirović S., Kovačević Z., Dugandžija T., Radovanović D., Stilinović N. (2024). Sales of veterinary antibiotics in Serbia: Identification of problem areas using standardized metrics. Animals; 14(22):3201. doi.:10.3390/ani14223201.
Uahupirapi K., Shifotoka S., Nangombe V. (2025). Factors contributing to human and veterinary medicine shortages in developing countries: Perspectives of suppliers and regulators in Namibia. Tropical Medicine and Health; 53:12–25. doi.:10.1186/s41182-025-00799-1.
Udhwani T., Dean K. R., Sommerset I., Helgesen K. O. (2025). Quality assessment of fish vaccine data in the Norwegian Veterinary Prescription Register (VetReg). BMC Veterinary Research; 21(1):17. doi.:10.1186/s12917-024-04460-7.
Udhwani T., Grave K., Hopp P., Helgesen K. O. (2025). Quality assessment of antibiotic use data in the Norwegian veterinary prescription register for 2023. BMC Veterinary Research; 21(1):510. doi.:10.1186/s12917-025-04903-9.
Van Boeckel T. P., Brower C., Gilbert M., et al. (2015). Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences of the United States of America; 112(18):5649–5654. doi.:10.1073/pnas.1503141112.
Vidhamaly V., Bellingham K., Newton P. N., Caillet C. (2022). The quality of veterinary medicines and their implications for One Health. BMJ Global Health; 7(8):e008564. doi.:10.1136/bmjgh-2022-008564.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 One Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
